Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 2146-2148, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biosca, C.
Right arrow Articles by Hyltoft Petersen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biosca, C.
Right arrow Articles by Hyltoft Petersen, P.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2001;47:2146-2148.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Reference Change Value Concept Combining Two Delta Values to Predict Crises in Renal Posttransplantation

Carmen Biosca1a, Carmen Ricós2, Ricardo Lauzurica1, Román Galimany1 and Per Hyltoft Petersen3

1 Hospital Universitari "Germans Trias i Pujol", 08916 Barcelona, Spain;
2 Hospital "Vall d’Hebron", 08035 Barcelona, Spain;
3 Odense University Hospital, 5000 Odense, Denmark

aaddress correspondence to this author at: Department of Biochemistry, Hospital "Germans Trias i Pujol", Ctra. de Canyet s/n, 08916 Barcelona, Spain. Fax 34-34-978-843, e-mail cbiosca@ns.hugtip.scs.es


   Introduction
 
The concept of reference change value (RCV) was developed by Harris and Yasaka (1)(2) to identify significant changes in the state of patients when monitoring their pathology. This concept can be applied to the laboratory data routinely acquired for renal posttransplantation patients to detect potential crises before clinical indications are manifested. The RCV takes into account the within-subject biological variation as well as the analytical (3)(4)(5)(6)(7) when:

In previous work using data from kidney transplantation patients (6)(8), we noted that the analytes most suitable for detecting significant changes during posttransplantation follow-up are serum creatinine, urate, and urea. We hypothesized that the predictive power of these analytes might greatly increase if more than one showed simultaneous and independent changes before the clinical manifestations of reduced kidney function became apparent.

We developed an objective analytical indicator (using these analytes) to detect potential subclinical crises in renal transplant recipients based on the RCV concept. To make the model relevant for use in daily practice, we attempted to include nephrologists’ criteria in the final values proposed by determining the factors they consider crucial when monitoring their transplant patients (9)(10). The underlying goal of this effort was to extract the most information possible from routine laboratory data and offer the clinician an improved tool for patient care.

To test whether the concentrations of creatinine, urea, and urate were independent, pairs of data from the three . . . [Full Text of this Article]


   Footnotes
 

   References
 



The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Pathol.Home page
F. Omar, G. F van der Watt, and T. S Pillay
Reference change values: how useful are they?
J. Clin. Pathol., April 1, 2008; 61(4): 426 - 427.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.